Mercè Brunet

1.2k total citations
24 papers, 422 citations indexed

About

Mercè Brunet is a scholar working on Transplantation, Surgery and Epidemiology. According to data from OpenAlex, Mercè Brunet has authored 24 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Transplantation, 9 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Mercè Brunet's work include Renal Transplantation Outcomes and Treatments (13 papers), Organ Transplantation Techniques and Outcomes (9 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Mercè Brunet is often cited by papers focused on Renal Transplantation Outcomes and Treatments (13 papers), Organ Transplantation Techniques and Outcomes (9 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Mercè Brunet collaborates with scholars based in Spain, Germany and United States. Mercè Brunet's co-authors include Olga Millán, Marçal Pastor‐Anglada, Pablo Ruíz, Gonzalo Crespo, Klemens Budde, Miquel Navasa, Jordi Colmenero, Lluís Guirado, Alba Díaz and Claudia Sommerer and has published in prestigious journals such as PLoS ONE, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Mercè Brunet

22 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mercè Brunet Spain 12 159 147 143 126 60 24 422
Speranța Iacob Romania 10 85 0.5× 164 1.1× 163 1.1× 89 0.7× 104 1.7× 33 431
Pavel Trunečka Czechia 14 355 2.2× 217 1.5× 332 2.3× 334 2.7× 32 0.5× 43 668
Daniel Foltys Germany 10 389 2.4× 94 0.6× 313 2.2× 495 3.9× 64 1.1× 22 729
Jolanta Żegarska Poland 10 118 0.7× 49 0.3× 29 0.2× 61 0.5× 91 1.5× 33 327
Camille Tron France 16 214 1.3× 130 0.9× 30 0.2× 112 0.9× 75 1.3× 46 568
L.S Leonardi Brazil 11 37 0.2× 92 0.6× 181 1.3× 219 1.7× 79 1.3× 38 463
S. Witte Germany 6 248 1.6× 83 0.6× 148 1.0× 224 1.8× 43 0.7× 14 444
K. Hama Japan 12 159 1.0× 47 0.3× 165 1.2× 275 2.2× 58 1.0× 34 523
M. H. Gleeson United Kingdom 7 155 1.0× 151 1.0× 103 0.7× 128 1.0× 20 0.3× 7 418
Maciej Głyda Poland 12 436 2.7× 78 0.5× 35 0.2× 218 1.7× 46 0.8× 44 602

Countries citing papers authored by Mercè Brunet

Since Specialization
Citations

This map shows the geographic impact of Mercè Brunet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mercè Brunet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mercè Brunet more than expected).

Fields of papers citing papers by Mercè Brunet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mercè Brunet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mercè Brunet. The network helps show where Mercè Brunet may publish in the future.

Co-authorship network of co-authors of Mercè Brunet

This figure shows the co-authorship network connecting the top 25 collaborators of Mercè Brunet. A scholar is included among the top collaborators of Mercè Brunet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mercè Brunet. Mercè Brunet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Julian, J.A., Olga Millán, Esther Titos, et al.. (2025). Donor-derived cell-free DNA and miRNA monitoring for the early prediction and diagnosis of liver allograft rejection and patient outcomes. Frontiers in Immunology. 16. 1604200–1604200.
2.
Panisello‐Roselló, Arnau, Jordi Colmenero, Mercè Brunet, et al.. (2024). Focusing on Ischemic Reperfusion Injury in the New Era of Dynamic Machine Perfusion in Liver Transplantation. International Journal of Molecular Sciences. 25(2). 1117–1117. 13 indexed citations
3.
Jiménez, Wladimiro, et al.. (2023). Genotype and Phenotype Influence the Personal Response to Prostaglandin Analogues and Beta-Blockers in Spanish Glaucoma and Ocular Hypertension Patients. International Journal of Molecular Sciences. 24(3). 2093–2093. 2 indexed citations
4.
Ambrosioni, Juan, Marta Bodro, M. Castel, et al.. (2023). Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir. Clinical Microbiology and Infection. 29(5). 655.e1–655.e4. 3 indexed citations
5.
Lemaı̂tre, F., Klemens Budde, Teun van Gelder, et al.. (2022). Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19. Therapeutic Drug Monitoring. 45(2). 191–199. 35 indexed citations
6.
Hernández‐Tejero, María, Fátima Aziz, Miquel Sanz, et al.. (2022). Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections. Journal of Antimicrobial Chemotherapy. 77(5). 1365–1371. 11 indexed citations
7.
Brunet, Mercè & Marçal Pastor‐Anglada. (2022). Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics. Pharmaceutics. 14(9). 1755–1755. 27 indexed citations
8.
Colom, Helena, Olga Millán, Cristina Espinosa, et al.. (2021). Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients. PLoS ONE. 16(1). e0245880–e0245880. 11 indexed citations
9.
Ambrosioni, Juan, Montserrat Tuset, Mercè Brunet, et al.. (2021). Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review. Infectious Diseases and Therapy. 10(2). 1055–1064. 5 indexed citations
10.
Millán, Olga, Jordi Rovira, Lluís Guirado, et al.. (2021). Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation. Clinical Immunology. 229. 108792–108792. 11 indexed citations
11.
Sommerer, Claudia, Mercè Brunet, Klemens Budde, et al.. (2021). Monitoring of gene expression in tacrolimus‐treated de novo renal allograft recipients facilitates individualized immunosuppression: Results of the IMAGEN study. British Journal of Clinical Pharmacology. 87(10). 3851–3862. 9 indexed citations
12.
Díaz‐González, Álvaro, Víctor Sapena, Loreto Boix, et al.. (2020). Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials. Liver International. 40(10). 2476–2488. 9 indexed citations
13.
Ruíz, Pablo, Olga Millán, José Ríos, et al.. (2020). MicroRNAs 155‐5p, 122‐5p, and 181a‐5p Identify Patients With Graft Dysfunction Due to T Cell–Mediated Rejection After Liver Transplantation. Liver Transplantation. 26(10). 1275–1286. 13 indexed citations
14.
Millán, Olga, Pablo Ruíz, Lara Orts, et al.. (2019). Monitoring of miR-181a-5p and miR-155-5p Plasmatic Expression as Prognostic Biomarkers for Acute and Subclinical Rejection in de novo Adult Liver Transplant Recipients. Frontiers in Immunology. 10. 873–873. 32 indexed citations
15.
16.
Millán, Olga, Eberhard Wieland, Pierre Marquet, & Mercè Brunet. (2019). Pharmacodynamic Monitoring of mTOR Inhibitors. Therapeutic Drug Monitoring. 41(2). 160–167. 10 indexed citations
17.
Millán, Olga, Klemens Budde, Claudia Sommerer, et al.. (2017). Urinary miR‐155‐5p and CXCL10 as prognostic and predictive biomarkers of rejection, graft outcome and treatment response in kidney transplantation. British Journal of Clinical Pharmacology. 83(12). 2636–2650. 49 indexed citations
18.
Mauro, Ezequiel, Gonzalo Crespo, Carla Montironi, et al.. (2017). Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C. Hepatology. 67(5). 1683–1694. 111 indexed citations
19.
Palao, Diego, et al.. (1994). Haloperidol. Journal of Clinical Psychopharmacology. 14(5). 303???310–303???310. 23 indexed citations
20.
Palao, Diego, et al.. (1992). PLASMA LEVELS OF HALOPERIDOL AND CLINICAL RESPONSE IN SCHIZOPHRENIA. Clinical Neuropharmacology. 15. 354B–354B. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Speranța Iacob Breakdown of academic impact, for papers by Pavel Trunečka Breakdown of academic impact, for papers by Daniel Foltys Breakdown of academic impact, for papers by Jolanta Żegarska Breakdown of academic impact, for papers by Camille Tron Breakdown of academic impact, for papers by L.S Leonardi Breakdown of academic impact, for papers by S. Witte Breakdown of academic impact, for papers by K. Hama Breakdown of academic impact, for papers by M. H. Gleeson Breakdown of academic impact, for papers by Maciej Głyda
Rankless by CCL
2026